{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:13:56Z","timestamp":1786119236585,"version":"build-2736575974"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1111\/j.1524-4725.2009.01149.x","type":"journal-article","created":{"date-parts":[[2009,3,30]],"date-time":"2009-03-30T15:37:57Z","timestamp":1238427477000},"page":"881-884","source":"Crossref","is-referenced-by-count":1,"title":["Poly-L-Lactic Acid for Correction of Localized Facial Lipoatrophy in an Otherwise Healthy Young Woman"],"prefix":"10.1097","volume":"35","author":[{"given":"Cheryl M.","family":"Burgess","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-27-20210206","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0002-9343(99)00414-3","article-title":"Lipodystrophies.","volume":"108","author":"Garg","year":"2000","journal-title":"Am J Med"},{"key":"R2-27-20210206","first-page":"1058","article-title":"Full scope of effect of facial lipoatrophy: a framework of disease understanding.","volume":"32","author":"Ascher","year":"2006","journal-title":"Dermatol Surg"},{"key":"R3-27-20210206","first-page":"369","article-title":"Relationship between lipoatrophy and quality of life.","volume":"15","author":"Echavez","year":"2005","journal-title":"AIDS Read"},{"key":"R5-27-20210206","first-page":"542","article-title":"Facial enhancement and the European experience with Sculptra (poly-L-lactic acid).","volume":"3","author":"Vleggaar","year":"2004","journal-title":"J Drugs Dermatol"},{"key":"R6-27-20210206","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaad.2004.08.056","article-title":"Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy.","volume":"52","author":"Burgess","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R7-27-20210206","first-page":"1336","article-title":"Safety and efficacy of poly-L-lactic acid injections in persons with HIV-associated lipoatrophy: the US experience.","volume":"32","author":"Mest","year":"2006","journal-title":"Dermatol Surg"},{"key":"R8-27-20210206","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jaad.2006.10.959","article-title":"En coup de sabre morphea and Parry-Romberg syndrome: a retrospective review of 54 patients.","volume":"56","author":"Tollefson","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"R9-27-20210206","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1468-1293.2004.00190.x","article-title":"A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection.","volume":"5","author":"Moyle","year":"2004","journal-title":"HIV Med"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1111\/j.1524-4725.2009.01149.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:47:54Z","timestamp":1786038474000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00042728-200905000-00027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1524-4725.2009.01149.x","relation":{},"ISSN":["1076-0512"],"issn-type":[{"value":"1076-0512","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}